No abstract available
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal* / economics
-
Antibodies, Monoclonal* / pharmacology
-
Antibodies, Monoclonal, Humanized
-
Anticholesteremic Agents / economics
-
Anticholesteremic Agents / pharmacology
-
Arteriosclerosis* / blood
-
Arteriosclerosis* / drug therapy
-
Cholesterol, LDL / blood
-
Cost-Benefit Analysis
-
Drug Approval
-
Eligibility Determination / methods
-
Female
-
Humans
-
Male
-
Medication Therapy Management
-
Middle Aged
-
PCSK9 Inhibitors*
-
Registries / statistics & numerical data
-
Treatment Outcome
-
United States
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Anticholesteremic Agents
-
Cholesterol, LDL
-
PCSK9 Inhibitors
-
PCSK9 protein, human
-
evolocumab